Follow
GIULIO PRETA
GIULIO PRETA
Institute of Life Science, Swansea University
Verified email at swansea.ac.uk
Title
Cited by
Cited by
Year
Dynasore-not just a dynamin inhibitor
G Preta, JG Cronin, IM Sheldon
Cell Communication and Signaling 13, 1-7, 2015
2832015
Lipids in the cell: organisation regulates function
AL Santos, G Preta
Cellular and molecular life sciences 75, 1909-1927, 2018
1042018
New insights into targeting membrane lipids for cancer therapy
G Preta
Frontiers in cell and developmental biology 8, 571237, 2020
772020
Protective role of the dynamin inhibitor Dynasore against the cholesterol-dependent cytolysin of Trueperella pyogenes
G Preta, V Lotti, JG Cronin, IM Sheldon
The FASEB Journal 29 (4), 1516, 2015
602015
Biological applications of tethered bilayer lipid membranes
T Penkauskas, G Preta
Biochimie 157, 131-141, 2019
342019
AIF and Scythe (Bat3) regulate phosphatidylserine exposure and macrophage clearance of cells undergoing Fas (APO-1)-mediated apoptosis
G Preta, B Fadeel
Public Library of Science 7 (10), e47328, 2012
332012
Tethered bilayer membranes as a complementary tool for functional and structural studies: The pyolysin case
G Preta, M Jankunec, F Heinrich, S Griffin, IM Sheldon, G Valincius
Biochimica et Biophysica Acta (BBA)-Biomembranes 1858 (9), 2070-2080, 2016
292016
Inhibiting mevalonate pathway enzymes increases stromal cell resilience to a cholesterol-dependent cytolysin
S Griffin, G Preta, IM Sheldon
Scientific reports 7 (1), 17050, 2017
272017
A role for nuclear translocation of tripeptidyl-peptidase II in reactive oxygen species-dependent DNA damage responses
G Preta, R de Klark, R Glas
Biochemical and biophysical research communications 389 (4), 575-579, 2009
272009
MAML1 acts cooperatively with EGR1 to activate EGR1-regulated promoters: implications for nephrogenesis and the development of renal cancer
ML Hansson, S Behmer, R Ceder, S Mohammadi, G Preta, RC Grafström, ...
Public Library of Science 7 (9), e46001, 2012
262012
Inhibition of Serine‐Peptidase Activity Enhances the Generation of a Survivin‐Derived HLA‐A2‐Presented CTL Epitope in Colon‐Carcinoma Cells
G Preta, D Marescotti, C Fortini, P Carcoforo, C Castelli, M Masucci, ...
Scandinavian journal of immunology 68 (6), 579-588, 2008
242008
Pleiotropic effects of statins via interaction with the lipid bilayer: A combined approach
T Penkauskas, A Zentelyte, S Ganpule, G Valincius, G Preta
Biochimica et Biophysica Acta (BBA)-Biomembranes 1862 (9), 183306, 2020
232020
MAP kinase-signaling controls nuclear translocation of tripeptidyl-peptidase II in response to DNA damage and oxidative stress
G Preta, R de Klark, S Chakraborti, R Glas
Biochemical and biophysical research communications 399 (3), 324-330, 2010
212010
The enigma of tripeptidyl-peptidase II: dual roles in housekeeping and stress
G Preta, R de Klark, R Gavioli, R Glas
Journal of Oncology 2010, 2010
182010
Scythe cleavage during Fas (APO-1)-and staurosporine-mediated apoptosis
G Preta, B Fadeel
FEBS letters 586 (6), 747-752, 2012
162012
Increased activity of catalase in tumor cells overexpressing IGFBP-2
A Hoeflich, O Fettscher, G Preta, H Lahm, HJ Kolb, E Wolf, MM Weber
Hormone and metabolic research 35 (11/12), 816-821, 2003
162003
Requirement of apoptotic protease-activating factor-1 for bortezomib-induced apoptosis but not for Fas-mediated apoptosis in human leukemic cells
A Ottosson-Wadlund, R Ceder, G Preta, K Pokrovskaja, RC Grafström, ...
Molecular Pharmacology 83 (1), 245-255, 2013
152013
Membrane cholesterol content and lipid organization influence melittin and pneumolysin pore-forming activity
S Ganpule, AK Vijaya, A Sukova, G Preta
Toxins 14 (5), 346, 2022
42022
Understanding the Dr. Jekyll and Mr. Hyde nature of apoptosis-inducing factor: future perspectives
G Preta
biomedical journal 40 (4), 239-240, 2017
32017
Targeting Lipid Rafts as a Strategy Against Infection and Cancer
T Garofalo, R Misasi, G Preta
Frontiers in cell and developmental biology 9, 748905, 2021
22021
The system can't perform the operation now. Try again later.
Articles 1–20